Invesco Nasdaq Biotechnology ETF Rating $24.48 +0.13 (+0.53%) (As of 07/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco Nasdaq Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBBQ Aggregate RatingModerate Buy2.63Holdings in IBBQ have an aggregate rating of Moderate Buy based on 688 analyst ratings issued in the past year covering 50 companies (80.9% of the portfolio).IBBQ Aggregate Price Target$27.1911.08% UpsideHigh Prediction$35.00Average Prediction$27.19Low Prediction$19.23Holdings in IBBQ have an aggregate price target of $27.19 and a range of $19.23 to $35.00 covering 50 companies (80.9% of the portfolio).IBBQ Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBBQ Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.35%GILDGilead Sciences$77.01+0.7%4.7931 of 5 stars4.79 / 5 stars2.33$81.81 6.2%18Options VolumeAnalyst Revision8.02%AMGNAmgen$334.85+0.2%4.4969 of 5 stars4.50 / 5 stars2.52$312.63 -6.6%21Short Interest ↑Analyst Revision7.92%REGNRegeneron Pharmaceuticals$1,078.63+1.4%4.2421 of 5 stars4.24 / 5 stars2.78$1,074.95 -0.3%23Upcoming EarningsAnalyst ForecastAnalyst Revision7.88%VRTXVertex Pharmaceuticals$495.26+0.6%3.9637 of 5 stars3.96 / 5 stars2.54$460.30 -7.1%26Upcoming EarningsAnalyst ForecastInsider Selling4.39%MRNAModerna$122.11+1.4%3.2392 of 5 stars3.24 / 5 stars2.28$133.88 9.6%18Upcoming EarningsInsider Selling3.73%AZNAstraZeneca$78.13-0.5%3.6246 of 5 stars3.62 / 5 stars2.90$88.00 12.6%10Short Interest ↓Analyst RevisionNews Coverage3.24%BIIBBiogen$211.17-7.2%4.8342 of 5 stars4.83 / 5 stars2.65$286.00 35.4%26Upcoming EarningsAnalyst ForecastShort Interest ↑Gap Down2.94%ALNYAlnylam Pharmaceuticals$234.84-1.3%3.3743 of 5 stars3.37 / 5 stars2.67$256.73 9.3%24Upcoming EarningsShort Interest ↑1.82%ILMNIllumina$120.43+2.7%4.8691 of 5 stars4.87 / 5 stars2.33$158.57 31.7%21Positive News1.58%BMRNBioMarin Pharmaceutical$84.59-1.2%4.8983 of 5 stars4.90 / 5 stars2.55$102.00 20.6%20Upcoming EarningsAnalyst ForecastShort Interest ↓Analyst RevisionNews Coverage1.48%INCYIncyte$68.61+0.1%4.6829 of 5 stars4.68 / 5 stars2.39$73.25 6.8%18Upcoming EarningsAnalyst ForecastNews Coverage1.46%ARGXargenx$494.46+1.7%1.0803 of 5 stars1.08 / 5 stars2.90$539.05 9.0%21Earnings ReportAnalyst UpgradeShort Interest ↑News CoverageHigh Trading Volume1.45%NBIXNeurocrine Biosciences$146.80+0.5%4.7048 of 5 stars4.70 / 5 stars2.78$154.08 5.0%23Upcoming EarningsAnalyst ForecastNews Coverage1.45%UTHRUnited Therapeutics$338.22+0.5%4.6412 of 5 stars4.64 / 5 stars2.83$330.64 -2.2%12Upcoming EarningsAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage1.42%SNYSanofi$52.40-1.3%1.323 of 5 stars1.32 / 5 stars2.25$55.00 5.0%5Analyst ForecastShort Interest ↑News Coverage1.37%VTRSViatris$12.08+2.7%1.5315 of 5 stars1.53 / 5 stars2.00$12.33 2.1%3Short Interest ↓News Coverage1.36%SRPTSarepta Therapeutics$144.24-2.2%4.9124 of 5 stars4.91 / 5 stars2.78$187.72 30.1%18Short Interest ↓1.27%RPRXRoyalty Pharma$28.79+0.4%4.8959 of 5 stars4.90 / 5 stars2.80$41.80 45.2%5Positive News1.18%INSMInsmed$74.54+0.1%3.158 of 5 stars3.16 / 5 stars3.00$74.50 -0.1%16Upcoming EarningsShort Interest ↑1.16%MEDPMedpace$381.47+0.3%4.9685 of 5 stars4.97 / 5 stars2.88$424.14 11.2%8Earnings ReportAnalyst UpgradeShort Interest ↓Analyst RevisionNews Coverage0.91%PCVXVaxcyte$84.05+0.5%0.2305 of 5 stars0.23 / 5 stars3.00$78.50 -6.6%4Insider SellingNews Coverage0.80%ITCIIntra-Cellular Therapies$80.39-0.6%4.6796 of 5 stars4.68 / 5 stars2.83$94.83 18.0%12Short Interest ↓News Coverage0.80%BNTXBioNTech$85.94+1.5%1.6002 of 5 stars1.60 / 5 stars2.20$111.70 30.0%10News Coverage0.78%ROIVRoivant Sciences$10.80+0.6%3.0371 of 5 stars3.04 / 5 stars2.90$17.10 58.3%100.76%RVMDRevolution Medicines$46.44+1.9%3.0391 of 5 stars3.04 / 5 stars3.08$50.67 9.1%120.76%ASNDAscendis Pharma A/S$133.75-0.5%3.4624 of 5 stars3.46 / 5 stars2.90$179.00 33.8%10Analyst RevisionNews CoveragePositive News0.73%IONSIonis Pharmaceuticals$51.45-0.8%3.8981 of 5 stars3.90 / 5 stars2.79$60.18 17.0%19Upcoming EarningsAnalyst ForecastAnalyst Revision0.71%BPMCBlueprint Medicines$112.19-1.3%0.604 of 5 stars0.60 / 5 stars2.63$116.33 3.7%16Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage0.69%SMMTSummit Therapeutics$11.55+10.1%0.9307 of 5 stars0.93 / 5 stars3.00$13.50 16.9%2Positive NewsGap Up0.69%BGNEBeiGene$162.54-0.4%2.3577 of 5 stars2.36 / 5 stars2.80$250.75 54.3%10Analyst Revision0.69%HALOHalozyme Therapeutics$56.23+0.5%4.8082 of 5 stars4.81 / 5 stars2.75$58.38 3.8%8Insider Selling0.68%JAZZJazz Pharmaceuticals$111.57+1.9%4.9598 of 5 stars4.96 / 5 stars2.80$185.86 66.6%15Upcoming Earnings0.64%EXELExelixis$23.39+1.9%4.8413 of 5 stars4.84 / 5 stars2.59$26.13 11.7%17Analyst RevisionNews Coverage0.64%CYTKCytokinetics$59.69+2.0%4.2478 of 5 stars4.25 / 5 stars2.83$77.06 29.1%18Insider Selling0.59%MDGLMadrigal Pharmaceuticals$284.49+0.4%4.2419 of 5 stars4.24 / 5 stars2.69$348.50 22.5%13Analyst Forecast0.58%KRYSKrystal Biotech$213.66+1.4%4.1872 of 5 stars4.19 / 5 stars3.00$177.63 -16.9%9Positive News0.49%BBIOBridgeBio Pharma$27.05+1.3%4.418 of 5 stars4.42 / 5 stars3.00$48.73 80.1%11Upcoming EarningsShort Interest ↑Gap Up0.48%LEGNLegend Biotech$56.61-4.3%3.1147 of 5 stars3.11 / 5 stars3.00$81.31 43.6%140.47%NUVLNuvalent$81.61+2.1%0.649 of 5 stars0.65 / 5 stars2.90$96.33 18.0%100.46%CRSPCRISPR Therapeutics$57.92+0.6%2.054 of 5 stars2.05 / 5 stars2.33$75.71 30.7%18Positive News0.45%APLSApellis Pharmaceuticals$39.75+2.2%4.3761 of 5 stars4.38 / 5 stars2.81$74.75 88.1%16Upcoming EarningsAnalyst ForecastNews Coverage0.44%ALKSAlkermes$27.88-0.6%4.6529 of 5 stars4.65 / 5 stars2.55$36.70 31.6%11Earnings ReportAnalyst ForecastNews Coverage0.42%RNAAvidity Biosciences$48.14+7.6%0.1262 of 5 stars0.13 / 5 stars3.00$44.29 -8.0%7Insider SellingShort Interest ↑News Coverage0.42%DYNDyne Therapeutics$44.53+4.3%1.3373 of 5 stars1.34 / 5 stars3.11$43.11 -3.2%9Upcoming EarningsPositive News0.41%CRNXCrinetics Pharmaceuticals$54.36+1.9%3.8667 of 5 stars3.87 / 5 stars2.92$64.08 17.9%12Insider SellingShort Interest ↑0.40%AXSMAxsome Therapeutics$86.53+0.6%4.6877 of 5 stars4.69 / 5 stars2.93$123.85 43.1%14Analyst ForecastAnalyst Revision0.40%IMVTImmunovant$29.10+4.7%1.1415 of 5 stars1.14 / 5 stars3.00$49.73 70.9%15Options Volume0.38%GHGuardant Health$33.00+3.4%4.5864 of 5 stars4.59 / 5 stars2.93$37.38 13.3%15Upcoming EarningsShort Interest ↓0.37%RAREUltragenyx Pharmaceutical$44.86-0.4%4.3748 of 5 stars4.37 / 5 stars2.93$86.50 92.8%14Upcoming EarningsAnalyst Forecast0.36%IBRXImmunityBio$5.61+2.2%0.2689 of 5 stars0.27 / 5 stars2.00$6.00 7.0%1Gap Up This page (NASDAQ:IBBQ) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
